[HTML][HTML] Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - Plos one, 2022 - journals.plos.org
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man… - PLoS ONE, 2022 - ui.adsabs.harvard.edu
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains.

FJ Li, L Starrs, A Mathur, H Ishii, SM Man… - PLoS ONE, 2022 - search.ebscohost.com
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

[PDF][PDF] Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - scholar.archive.org
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

[HTML][HTML] Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - PLOS ONE, 2022 - ncbi.nlm.nih.gov
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains.

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - PLoS ONE, 2022 - go.gale.com
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man… - PloS one, 2022 - pubmed.ncbi.nlm.nih.gov
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - bioRxiv, 2022 - biorxiv.org
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains.

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - Plos one, 2022 - europepmc.org
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains.

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - Plos one, 2022 - europepmc.org
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …